What is QMS Medical Allied Services Ltd revenue growth outlook?

QMS Medical Allied Services Ltd operates in the Healthcare Equipment & Supplies sector and has a current market cap of ₹350 Cr and P/E ratio of 32.58. For detailed revenue growth insights derived from the latest earnings call, visit the QMS Medical Allied Services Ltd analysis page on Arthneeti AI.

What is QMS Medical Allied Services Ltd current stock price?

QMS Medical Allied Services Ltd current market price is ₹181.17. The stock trades at a P/E ratio of 32.58 with a market capitalisation of ₹350 Cr.

How does Arthneeti AI analyse QMS Medical Allied Services Ltd?

Arthneeti AI uses natural language processing to analyse QMS Medical Allied Services Ltd's earnings call transcripts and extract key insights on revenue growth, margins, capex plans, and fundraising activity. The analysis covers management commentary, forward guidance, and competitive positioning within the Healthcare Equipment & Supplies sector.

QMS Medical Allied Services Q1 FY27 Share Price & Earnings Call Analysis

₹181.17+2.25% today

Market cap: ₹350 Cr
P/E: 32.58
ROE: 10.45%
Price to sales: 1.91
Debt to equity: 0.71
52W high / low: ₹217 / ₹72.0
EBITDA margin: 15.23%
Net profit margin: 6.90%
Promoter holding: 68.11%
Sales (last year): ₹183 Cr

All 10 ratios ↓

Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]

Guidance scorecard · Q1 FY27 call

What QMS Medical Allied Services Ltd's management guided
and where it ranks in Healthcare Equipment & Supplies

Revenue20–40%MarginsFlat CapexWhat management said FundraisingWhat management said Order bookWhat management said

RevenueQ1 FY27 call

20–40%

QMS expects continued growth in patient support programs (PSP) contributing INR90-105 crores revenue in FY27, driven by expanded contracts and new initiatives.
Product business growth is supported by Q Devices, targeting 20-25% of total product revenue within 3 years, with 17+ products currently launched and more in the pipeline.
Service revenue, including PSP and camps, is increasing with a higher contribution to margins due to strategic focus.
B2B health camps increased 40% YoY, supporting early diagnosis and awareness, expected to continue scaling.
The company aims to maintain around INR220 crores top-line guidance for FY27, with potential upward revision post Q2/Q3.

2 more points from QMS Medical Allied Services Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

The company expects an uptick in performance over the earlier quarters to continue, with average margins projected to be higher by the end of FY27, aiming around 16%-20% EBITDA margin.
EBITDA margin guidance of approximately 18% for FY27 remains intact based on current ramp-up and projections.
Employee costs expected to remain stable with possible 5%-10% variation depending on hirings; new hirings will be backed by contracts.
Revenue growth driven by expansion in services (such as PSPs and Q Devices), with services revenue expected at INR90-105 crores in FY27.
Q Devices segment targeted to contribute 20%-25% of product revenue in the next 2-3 years.

2 more points from QMS Medical Allied Services Ltd's call on margins

Create a free account to keep reading this call

See what QMS Medical Allied Services Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Emphasis is placed on scaling the service business, particularly patient service programs (PSPs), expanding the product business led by Q-Devices and Point of Care Solutions.
The company plans to grow Q-Devices product offerings from 17 products currently, targeting 20-25% of total product revenue from Q-Devices within 3 years, implying investment in product development and technology.
Focus on leveraging technology across the healthcare ecosystem for scalable, measurable, and data-driven service delivery suggests strategic investment in technology platforms.
Hiring plans are aligned with contractual wins, indicating careful operational investment rather than large upfront capex.

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what QMS Medical Allied Services Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

PSPs typically operate on annual contracts with renewals toward year-end; hence, a specific "order book" is not defined in the traditional sense.
PSP contracts are cost-plus with markup; employee and admin costs are passed to clients, so hiring aligns with contract commitments.
Current PSP revenue run rate suggests strong growth, with INR17 crores in Q1 FY27 and an expected INR90-105 crores for the full year.
Contract renewals historically exhibit a 60-70% roll-over rate annually, ensuring revenue visibility from existing clients.

2 more points from QMS Medical Allied Services Ltd's call on the order book

Create a free account to keep reading this call

Full Q1 FY27 analysis

Full Healthcare Equipment & Supplies ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance

See all potential multibaggers Where does QMS Medical Allied Services Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

1. Pick 3–15 stocks
2. Choose large, mid or small cap and your sectors
3. Get a portfolio built from the rankings

Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Equipment & Supplies companies ranked on guidance

#	Company	Revenue guided	Margin guided	Market cap	P/E
1		40%+	Flat	₹627 Cr	21.4
2		40%+	Flat	₹147 Cr	16.8
3	Q-Line Biotech	20–40%	Up 2%+	₹1,467 Cr	25.9
4		20–40%	Flat	₹18,144 Cr	83.6
5		20–40%	Flat	₹173 Cr	35.0
6		10–20%	Up 2%+	₹170 Cr	18.8

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Equipment & Supplies ranking

Financials of QMS Medical Allied Services Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.